Page last updated: 2024-11-06

mitomycin and Uveal Effusion Syndrome

mitomycin has been researched along with Uveal Effusion Syndrome in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Uveal Effusion Syndrome: Rare disease characterized by suprachoroidal fluid accumulation between the CHOROID and the SCLERA, annular detachment of the CHOROID, often with secondary RETINAL DETACHMENT; OPTIC DISK EDEMA, and minimal signs of UVEITIS and INTRAOCULAR PRESSURE changes.

Research Excerpts

ExcerptRelevanceReference
"To describe the use of topical mitomycin-C in sclerostomy revision for recalcitrant idiopathic uveal effusion syndrome."8.02APPLICATION OF ADJUNCTIVE TOPICAL MITOMYCIN-C IN SCLEROSTOMY REVISION FOR REFRACTORY IDIOPATHIC UVEAL EFFUSION SYNDROME. ( Ali, MH; Chang, PY; Haq, Z; Mieler, WF; Zahid, S; Zhu, I, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhu, I1
Haq, Z1
Ali, MH1
Chang, PY1
Zahid, S1
Mieler, WF1

Other Studies

1 other study available for mitomycin and Uveal Effusion Syndrome

ArticleYear
APPLICATION OF ADJUNCTIVE TOPICAL MITOMYCIN-C IN SCLEROSTOMY REVISION FOR REFRACTORY IDIOPATHIC UVEAL EFFUSION SYNDROME.
    Retinal cases & brief reports, 2021, Jul-01, Volume: 15, Issue:4

    Topics: Administration, Topical; Humans; Male; Middle Aged; Mitomycin; Sclerostomy; Treatment Outcome; Uveal

2021